Search Within

Bob Tingkan Li

Formats
  1. Meeting Abstract (143)
  2. Journal Article (122)
  3. Review (7)
  4. Editorial (4)
  5. Conference Paper (1)
  6. Correspondence (1)
  7. Research Letter (1)
Groups
  1. Department of Medicine (279)
  2. Solid Tumor Oncology Division (279)
  3. Thoracic Oncology (279)
  4. GSK Faculty (133)
  5. Department of Pathology and Laboratory Medicine (120)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (111)

More Groups

People
  1. Charles Rudin (72)
  2. Alexander Drilon (65)
  3. Maria Arcila (64)
  4. Mark Kris (57)
  5. Michael Offin (53)
  6. Michael Berger (49)

More People

Years
  1. 2025 (7)
  2. 2024 (39)
  3. 2023 (33)
  4. 2022 (29)
  5. 2021 (38)
  6. 2020 (27)

More Years

Publications
  1. Journal of Clinical Oncology (64)
  2. Journal of Thoracic Oncology (37)
  3. Annals of Oncology (28)
  4. Clinical Cancer Research (14)
  5. Cancer Research (13)
  6. JCO Precision Oncology (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (76)
  2. Elsevier Inc. (50)
  3. Oxford University Press (38)
  4. American Association for Cancer Research (36)
  5. Nature Publishing Group (15)
  6. Elsevier Ireland Ltd. (6)

More Publishers

Results (279)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brain metastases in patients with fusion-positive lung cancers
    Meeting Abstract

    Sui, J. S.; Chen, M. F.; Wilcox, J.; Yang, S. R.; Li, B. T.; Riely, G. J.; Offin, M.; Yu, H. A.; Kris, M. G.; Drilon, A. E.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • CodeBreaK 101: Safety and efficacy of sotorasib with carboplatin and pemetrexed in KRAS G12C-mutated advanced NSCLC
    Meeting Abstract

    Clarke, J. M.; Felip, E.; Li, B. T.; Ruffinelli, J. C.; Garrido, P.; Zugazagoitia, J.; Goldberg, S. B.; Ramalingam, S. S.; Victoria, I.; Puri, S.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Real-world landscape analysis of activating ERBB2/ERBB3 alterations in 107,561 tissue and plasma samples from patients with NSCLC
    Meeting Abstract

    Liu, D.; Jee, J.; Keller, R. B.; Schrock, A. B.; Drilon, A.; Oxnard, G. R.; Li, B. T.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Disparities in stage at presentation among Hispanic and Latinx patients with non-small cell lung cancer
    Meeting Abstract

    Dee, E. C.; Swami, N.; Li, B. T.; Florez, N.; Gomez, D. R.
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Clinical and genomic predictors of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer
    Meeting Abstract

    Arbour, K. C.; Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Characterization of diverse targetable alterations in ERBB2 and ERBB3 in 93,465 non-small cell lung cancers (NSCLC)
    Meeting Abstract

    Liu, D.; Keller, R. B.; Heilmann, A. M.; Allen, J.; Oxnard, G. R.; Bazhenova, L.; Schrock, A. B.; Li, B. T.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Analytical and clinical validation of oncomine Dx target (ODxT) test and local testing for identifying patients with HER2 (ERBB2)-mutant (HER2m) non–small-cell lung cancer (NSCLC) for treatment with trastuzumab deruxtecan (T-DXd) in DESTINY-Lung01/02 (DL-01/02)
    Meeting Abstract

    Li, B. T.; De Langen, A.; Goto, K.; Vitazka, P.; Qi, Z.; Ha, T.; Velasco Roth, A. M.; Karnoub, M.; Feng, W.; Pereira, K.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Prognostic and predictive implications of plasma ctDNA in guiding first-line targeted therapy for metastatic HER2 -mutant non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Liu, S. Y.; Jee, J.; Santini, F. C.; Schoenfeld, A. J.; Eichholz, J.; Johnson, K.; Martinez, A.; Guo, J.; Riaz, N.; Lee, N. Y.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Liu, D.; Makker, V.; Buonocore, D. J.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Johnson, A.; Offin, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 1/2 study of a first-in-human immune-stimulating antibody conjugate (ISAC) BDC-1001 in patients with advanced HER2-expressing solid tumors
    Meeting Abstract

    Li, B. T.; Pegram, M. D.; Lee, K. W.; Sharma, M.; Lee, J.; Spira, A. I.; Hanna, G. J.; Kang, Y. K.; Rasco, D. W.; Moore, K. N.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save